ELDN: Eledon Pharmaceuticals, Inc. Stock

by  •  • Comments Off on ELDN: Eledon Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 179.65
Enterprise Value ($M) 159.10
Book Value ($M) 118.14
Book Value / Share 1.97
Price / Book 1.52
NCAV ($M) 84.47
NCAV / Share 1.41
Price / NCAV 2.13

Profitability (mra)
Return on Invested Capital (ROIC) -0.30
Return on Assets (ROA) -0.45
Return on Equity (ROE) -0.48

Liquidity (mrq)
Quick Ratio 12.42
Current Ratio 12.42

Balance Sheet (mrq) ($M)
Current Assets 143.73
Assets 177.41
Liabilities 59.27
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -70.58
Net Income -36.18
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -47.27
Cash from Investing -70.31
Cash from Financing 133.52

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Frazier Life Sciences Public Fund, L.P. 2.00 -66.96
02-14 13G/A Armistice Capital, Llc 4.99 32.72
11-05 13G Ra Capital Management, L.p. 6.10
10-31 13G/A Biotechnology Value Fund L P 10.50 45.45

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-03-20 10-K on UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K
2024-11-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-08-19 10-Q/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q/A (Amendment No. 1)
2024-08-19 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 2)
2024-08-19 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q
2024-04-26 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K/A (Amendment No. 1)

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-17 9,632 135,145 7.13
2025-04-16 13,894 146,124 9.51
2025-04-15 24,188 140,487 17.22

(click for more detail)

Similar Companies
DWTX – Dogwood Therapeutics, Inc. DYAI – Dyadic International, Inc.
EDSA – Edesa Biotech, Inc. ELEV – Elevation Oncology, Inc.
ELTX – Elicio Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io